Cary Street Partners Investment Advisory’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Sell
954
-219
-19% -$45.5K 0.05% 345
2026
Q1
$248K Buy
1,173
+185
+19% +$39.8K 0.06% 305
2025
Q4
$203K Buy
+988
New +$186K 0.05% 330
2023
Q4
Sell
-188
Closed -$16.3K 789
2023
Q3
$16.3K Buy
188
+167
+795% +$15.1K ﹤0.01% 1173
2023
Q2
$1.99K Hold
21
﹤0.01% 1588
2023
Q1
$1.59K Hold
21
﹤0.01% 1527
2022
Q4
$1.61K Buy
+21
New +$1.6K ﹤0.01% 1532
2020
Q4
Sell
-599
Closed -$28K 425
2020
Q3
$28K Buy
+599
New +$30.7K 0.01% 587

Other funds holding CAH

Cary Street Partners Investment Advisory's CAH Position: Q2 2026 in Review

Cary Street Partners Investment Advisory reduced its Cardinal Health (CAH) stake by 19% in Q2 2026, selling an estimated $45.5K and leaving 954 shares worth $227K. The position accounts for 0.05% of the portfolio, ranked #345.

Cary Street Partners Investment Advisory first reported a position in CAH in Q3 2020 and has held it in 8 quarters since. The position peaked at $248K in Q1 2026. 1,049 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Cary Street Partners Investment Advisory held 954 shares of Cardinal Health worth $227K as of Q2 2026.
  • Cary Street Partners Investment Advisory sold 219 Cardinal Health shares in Q2 2026, an estimated $45.5K.
  • Cardinal Health made up 0.05% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #345 holding.
  • Cary Street Partners Investment Advisory first reported a position in Cardinal Health in Q3 2020 and has held it in 8 quarters since.
  • Cary Street Partners Investment Advisory's Cardinal Health position peaked at $248K in Q1 2026.
  • 1,049 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.